Intellia Therapeutics Inc [NTLA] Revenue clocked in at $45.57 million, down -51.55% YTD: What’s Next?
Intellia Therapeutics Inc [NASDAQ: NTLA] stock went on an upward path that rose over 8.49% on Tuesday, amounting to a one-week price increase of more than 18.55%. Over the last 12 months, NTLA stock dropped by -4.63%. The one-year Intellia Therapeutics Inc stock forecast points